American Journal of Psychiatry Audio
American Journal of Psychiatry
Recent Episodes
Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio to discuss a phase 3 randomized controlled trial looking at the use of the antipsychotic medication lumateperone as adjunctive to antidepressant therapy in the treatment of patients with major depressive disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the December issue of the Journal.
- 00:48 Durgam interview
- 03:09 Mechanism of action
- 04:44 Patient-reported outcomes
- 06:31 Immediate clinical implications
- 07:32 Limitations
- 08:08 Further research
- 09:25 Kalin interview
- 09:38 Durgam et al.
- 13:09 Lin et al.
- 17:22 Brodsky et al.
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
Dr. Lara Coughlin (University of Michigan, Ann Arbor) joins AJP Audio to discuss a study looking the impact of contingency management on all cause mortality in patients with stimulant use disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the November issue of the Journal.
- 01:09 Coughlin interview
- 02:05 Stimulant use disorder and contingency management
- 04:37 Mortality
- 05:12 Contingency management and "moral hazard"
- 08:30 Clinical uptake of contingency management
- 09:28 Broader applicability to psychiatric conditions
- 10:31 Limitations
- 11:39 Further research
- 12:32 Kalin interview
- 12:49 Coughlin et al.
- 16:41 Yalcinbas et al.
- 22:22 Na et al.
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
Dr. Shau-Ming Wei (National Institute of Mental Health, Bethesda, MD) joins AJP Audio to discuss a replication study looking at impact of hormone addback to a hormone suppression regimen for the treatment of premenstrual dysphoric disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the October issue of the Journal.
- 00:34 Wei interview
- 02:59 PMDD
- 04:22 Up and downsides of hormone suppression
- 05:52 Hormone addback
- 07:15 Limitations of the current study
- 08:38 Further research
- 10:42 Kalin interview
- 10:58 Wei et al.
- 15:25 Sanacora et al.
- 20:07 Whittle et al.
- 23:06 Cooper et al.
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
Dr. Deidre Anglin (City College, CUNY, New York) joins AJP Audio to discuss the disparate impact of schizophrenia spectrum disorder diagnosis on racial and ethnic minorities in the United States based on localized neighborhood data. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the September issue of the Journal.
- 00:31 Anglin interview
- 04:40 Zip code sizes
- 05:18 The long legacy of redlining
- 07:17 Socially vulnerable neighborhoods
- 09:43 Structural racism, clinicians, and working with individuals
- 13:45 Limitations
- 15:56 Further research
- 18:08 Kalin interview
- 18:13 Anglin et al.
- 25:19 Vano et al.
- 29:40 Moussa-Tooks et al.
- 33:34 Zhang et al.
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]
Dr. Vinod Rao (Massachusetts General Hospital, Boston) join AJP Audio to discuss predicting the relative risk of patients with an ADHD diagnosis developing a later stimulant or substance use disorder based on the method of prescription, in person or via telehealth. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the August issue of the Journal.
- 00:07 Rao interview
- 01:53 Stimulant use disorder versus substance use disorder
- 02:59 Cohort size and incidence of SUDs
- 04:28 Length of clinician engagement in non-profit versus for profit hospital systems
- 05:18 Patient cohort
- 06:20 Potential difference in mechanism between prescribing practices
- 07:35 Continued use of telehealth
- 08:43 Limitations
- 10:03 Further research
- 11:17 Kalin interview
- 11:24 Rao et al.
- 15:41 Mahjani et al.
- 19:59 Zhang et al.
- 25:11 Sha et al.
- 29:33 Gao and Olfson
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at [email protected]